Company intelligence / Profile preview

Petalion Therapeutics

Cambridge, England, United Kingdom

Ownership: Private
Development stage: Other

Overview

Petalion Therapeutics is a newly established biotech co-founded by Starpharma and Medicxi, leveraging the DEP dendrimer platform to develop targeted dendrimer-drug conjugate therapies for oncology. No clinical results are available yet as the lead candidate is still in preclinical development.

Therapeutic areas: Oncology
Modalities: Dendrimer-drug conjugateBiologic
Industry: Biotech

Partnerships

StarpharmaMedicxi

Beyond the preview

Go deeper on Petalion Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Petalion Therapeutics.

Explore the full profile